Stockreport

Hikma Pharmaceuticals PLC (HKMPF) Full Year 2025 Earnings Call Highlights: Strong EBITDA ... [Yahoo! Finance]

HIKMA PHARMS PLC S/ADR  (HKMPY) 
NASDAQ:AMEX Investor Relations: hikma.com/en/investors.html
PDF This article first appeared on GuruFocus EBITDA Margins: 25%, outperforming competitors aiming for 22%. EBIT for Generic Business: GBP 100 million with margins clos [Read more]